Verastem Oncology (VSTM) Announces Proposed Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- S&P 500, Dow futures rise ahead of big bank results, CPI data
- Oil prices rise as Iran deploys new tactics to target tankers
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Verastem (VSTM) PT Lowered to $7 at B.Riley
July 24, 2024 7:02 AM EDTB.Riley analyst Kalpit Patel lowered the price target on Verastem (NASDAQ: VSTM) to $7.00 (from $21.00) while maintaining a Buy rating.
The analyst comments "Verastem (VSTMBuy, $7 PT) announced a proposed public offering after market close on 7/23/24. Our enthusiasm for the drugs potential... More



